277410 — Insan Income Statement
0.000.00%
- KR₩43bn
- KR₩82bn
- KR₩36bn
Annual income statement for Insan, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 38,308 | 33,538 | 37,300 | 32,484 | 35,804 |
| Cost of Revenue | |||||
| Gross Profit | 23,926 | 20,501 | 23,474 | 17,968 | 19,760 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 30,145 | 28,833 | 31,559 | 31,668 | 33,673 |
| Operating Profit | 8,163 | 4,705 | 5,741 | 816 | 2,131 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 7,687 | 4,038 | 6,214 | 991 | 876 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 6,395 | 3,798 | 4,972 | 886 | 637 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 6,327 | 3,775 | 4,969 | 887 | 652 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 6,378 | 4,477 | 4,969 | 887 | 652 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 208 | 118 | 127 | 18.2 | 16.2 |
| Dividends per Share |